The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital is combating immune-mediated diseases by integrating patient care, basic and clinical research and education of physician-scientists.
Andrew D. Luster, MD, PhD, Chief of Service, Rheumatology, Allergy and Immunology Division
The Rheumatology Unit provides comprehensive, personalized care for patients with arthritis and other rheumatologic and autoimmune conditions. It includes the Rheumatology Clinical Research Unit, which currently is conducting clinical trials of novel therapies for lupus, rheumatoid arthritis, IgG4-related systemic disease and osteoarthritis.
The Allergy & Clinical Immunology Unit delivers expert care for the most common to very rare allergic and immunologic conditions. It houses the Allergy Clinical Research Unit, which presently is enrolling patients in clinical trials of chronic sinusitis, nasal polyps and asthma. The Clinical Immunology Laboratory, which provides specialized immunological testing for the Mass General medical community, is also part of the Allergy & Clinical Immunology Unit.
The Vasculitis and Glomerulonephritis Center brings together experts in rheumatology and nephrology to conduct leading-edge research and provide specialty care for patients with vasculitis, glomerulonephritis and related conditions.
The Center for Immunology and Inflammatory Diseases (CIID) is the major laboratory research component of our division. This state-of-the art, multidisciplinary research facility focuses on basic mechanisms of immune-mediated diseases.
Massachusetts General Hospital is recognized as a leader in patient care, education and research, ranking among the most prestigious medical institutions.
U.S. News & World Report ranks Mass General rheumatology in the top 10 among U.S. hospitals.